Atlanta
Merial has plans to relocate and consolidate its five major U.S. animal health operations to several sites in Georgia. A suburb of Atlanta will be selected for the company's North American headquarters, where 400 employees will be housed. The company's Athens, Ga., manufacturing and research facility will accommodate an additional 80 relocated R&D employees. The University of Georgia will be the site of a planned pilot vaccine development facility, where Merial would manufacture both animal and human vaccines.
